Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.
School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia. gerald.watts@uwa.edu.au
Gerald F
GF
Watts
Dick C
DC
Chan
D000818:Animals; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage*; D053767:Glucagon-Like Peptide 2 / Q000008:administration & dosage*; D006949:Hyperlipidemias / Q000378:metabolism*; D007333:Insulin Resistance / Q000502:physiology*; D007422:Intestines / Q000187:drug effects*; D008074:Lipoproteins / Q000096:biosynthesis*; D008297:Male; D019518:Postprandial Period / Q000187:drug effects*
D053767:Glucagon-Like Peptide 2; D008074:Lipoproteins; D052216:Glucagon-Like Peptide 1